The Fund announced plans to offer shares of its newly designated Series 2031 Term Preferred Shares in an underwritten public offering, according to a company statement.

The public offering price and other terms remain to be determined through negotiations between the company and underwriters. Oxford Lane plans to grant underwriters a 30-day option to purchase additional preferred shares to cover over-allotments.

The preferred stock is expected to be listed on the NASDAQ Global Select Market and begin trading within 30 days of the original issue date. The company expects to use net proceeds to repay outstanding debt or for general working capital purposes. As of 2026-03-11, the Fund’s leverage was 31.8% and Collateralized Loan Obligation Group leverage was 33.5%.